Show simple item record

dc.contributor.authorHarper, JC
dc.contributor.authorGeraedts, J
dc.contributor.authorBorry, P
dc.contributor.authorCornel, MC
dc.contributor.authorDondorp, W
dc.contributor.authorGianaroli, L
dc.contributor.authorHarton, G
dc.contributor.authorMilachich, T
dc.contributor.authorKääriäinen, H
dc.contributor.authorLiebaers, I
dc.contributor.authorMorris, M
dc.contributor.authorSequeiros, J
dc.contributor.authorSermon, K
dc.contributor.authorShenfield, F
dc.contributor.authorSkirton, Heather
dc.contributor.authorSoini, S
dc.contributor.authorSpits, C
dc.contributor.authorVeiga, A
dc.contributor.authorVermeesch, JR
dc.contributor.authorViville, S
dc.contributor.authorde Wert, G
dc.contributor.authorMacek, M
dc.date.accessioned2016-09-29T11:20:20Z
dc.date.available2016-09-29T11:20:20Z
dc.date.issued2013-11
dc.identifier.issn1018-4813
dc.identifier.issn1476-5438
dc.identifier.urihttp://hdl.handle.net/10026.1/5506
dc.description.abstract

In March 2005, a group of experts from the European Society of Human Genetics and European Society of Human Reproduction and Embryology met to discuss the interface between genetics and assisted reproductive technology (ART), and published an extended background paper, recommendations and two Editorials. Seven years later, in March 2012, a follow-up interdisciplinary workshop was held, involving representatives of both professional societies, including experts from the European Union Eurogentest2 Coordination Action Project. The main goal of this meeting was to discuss developments at the interface between clinical genetics and ARTs. As more genetic causes of reproductive failure are now recognised and an increasing number of patients undergo testing of their genome before conception, either in regular health care or in the context of direct-to-consumer testing, the need for genetic counselling and preimplantation genetic diagnosis (PGD) may increase. Preimplantation genetic screening (PGS) thus far does not have evidence from randomised clinical trials to substantiate that the technique is both effective and efficient. Whole-genome sequencing may create greater challenges both in the technological and interpretational domains, and requires further reflection about the ethics of genetic testing in ART and PGD/PGS. Diagnostic laboratories should be reporting their results according to internationally accepted accreditation standards (International Standards Organisation - ISO 15189). Further studies are needed in order to address issues related to the impact of ART on epigenetic reprogramming of the early embryo. The legal landscape regarding assisted reproduction is evolving but still remains very heterogeneous and often contradictory. The lack of legal harmonisation and uneven access to infertility treatment and PGD/PGS fosters considerable cross-border reproductive care in Europe and beyond. The aim of this paper is to complement previous publications and provide an update of selected topics that have evolved since 2005.

dc.format.extentS1-S21
dc.format.mediumPrint
dc.languageen
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.subjectAnimals
dc.subjectCongenital Abnormalities
dc.subjectDisease Models, Animal
dc.subjectEmbryonic Stem Cells
dc.subjectEpigenesis, Genetic
dc.subjectEurope
dc.subjectFemale
dc.subjectFertilization in Vitro
dc.subjectGenetic Counseling
dc.subjectGenetic Testing
dc.subjectGenetic Variation
dc.subjectGenetics, Medical
dc.subjectGuidelines as Topic
dc.subjectHumans
dc.subjectInfertility
dc.subjectMale
dc.subjectMedical Tourism
dc.subjectPolicy
dc.subjectPregnancy
dc.subjectPreimplantation Diagnosis
dc.subjectRegenerative Medicine
dc.subjectReproduction
dc.subjectReproductive Techniques, Assisted
dc.subjectSocieties, Scientific
dc.titleCurrent issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327440600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issueS2
plymouth.volume21
plymouth.publication-statusPublished
plymouth.journalEuropean Journal of Human Genetics
dc.identifier.doi10.1038/ejhg.2013.219
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
dc.publisher.placeEngland
dc.identifier.eissn1476-5438
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1038/ejhg.2013.219
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV